Your browser doesn't support javascript.
loading
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics.
Lonn, Eva; Bosch, Jackie; Pogue, Janice; Avezum, Alvaro; Chazova, Irina; Dans, Antonio; Diaz, Rafael; Fodor, George J; Held, Claes; Jansky, Petr; Keltai, Matyas; Keltai, Katalin; Kunti, Kamlesh; Kim, Jae-Hyung; Leiter, Lawrence; Lewis, Basil; Liu, Lisheng; Lopez-Jaramillo, Patricio; Pais, Prem; Parkhomenko, Alexandr; Peters, Ron J G; Piegas, Leopoldo S; Reid, Christopher M; Sliwa, Karen; Toff, William D; Varigos, John; Xavier, Denis; Yusoff, Khalid; Zhu, Jun; Dagenais, Gilles; Yusuf, Salim.
Afiliación
  • Lonn E; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada. Electronic address: eva.lonn@phri.ca.
  • Bosch J; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Pogue J; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Avezum A; Dante Pazzanese Institute of Cardiology, São Paulo, Brazil.
  • Chazova I; Russian Cardiology Research Complex, Moscow, Russian Federation.
  • Dans A; College of Medicine of the University of the Philippines, Manula, Philippines.
  • Diaz R; Fundacion ECLA, Rosario, Argentina.
  • Fodor GJ; University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Held C; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Jansky P; University Hospital Motol, Prague, Czech Republic.
  • Keltai M; Hungarian Institute of Cardiology, Semmelweis University, Budapest, Hungary.
  • Keltai K; Hungarian Institute of Cardiology, Semmelweis University, Budapest, Hungary.
  • Kunti K; Diabetes Research Centre, University of Leicester, Leicester, United Kingdom.
  • Kim JH; St. Paul's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Leiter L; Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Lewis B; Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Liu L; Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Lopez-Jaramillo P; Fundacion Oftalmolgica de Santander (FOSCAL) and Instituto Masira, Medical School, Universidad de Santander, Bucaramanga, Colombia.
  • Pais P; Division of Clinical Research and Training, St. John's Research Institute, Bangalore, India.
  • Parkhomenko A; Ukranian Strazhesko Institute of Cardiology, Kiev, Ukraine.
  • Peters RJ; Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands.
  • Piegas LS; Hospital do Coração, São Paulo, Brazil.
  • Reid CM; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
  • Sliwa K; Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, University of Cape Town and Soweto Cardiovascular Research Group, University of the Witwatersrand, Johannesburg, South Africa.
  • Toff WD; Department of Cardiovascular Sciences, University of Leicester and Leicester NIHR Biomedical Research Unit in Cardiovascular Disease, Glenfield Hospital, Leicester, United Kingdom.
  • Varigos J; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
  • Xavier D; Division of Clinical Research and Training, St. John's Research Institute, Bangalore, India.
  • Yusoff K; Universiti Teknologi MARA, Selangor, Malaysia.
  • Zhu J; Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Dagenais G; Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, Canada.
  • Yusuf S; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
Can J Cardiol ; 32(3): 311-8, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26481083
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_cobertura_universal / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cardiovascular_diseases Asunto principal: Prevención Primaria / Tetrazoles / Bencimidazoles / Presión Sanguínea / Enfermedades Cardiovasculares / Rosuvastatina Cálcica / Hidroclorotiazida / LDL-Colesterol Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Can J Cardiol Asunto de la revista: CARDIOLOGIA Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_cobertura_universal / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cardiovascular_diseases Asunto principal: Prevención Primaria / Tetrazoles / Bencimidazoles / Presión Sanguínea / Enfermedades Cardiovasculares / Rosuvastatina Cálcica / Hidroclorotiazida / LDL-Colesterol Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Can J Cardiol Asunto de la revista: CARDIOLOGIA Año: 2016 Tipo del documento: Article